Matt Spraker
@SprakerMDPhD
Followers
5K
Following
57K
Media
1K
Statuses
19K
Oncologist and Talking Head | ❤️ @mellysprakes, Aayla, Brooklyn the Dog, and the mountains
Denver, CO
Joined January 2009
A blog post on CHALLENGE and why you should be prescribing exercise today #ASCO25 A 🧵 with some resources for you:
6
16
104
Great post
0
1
4
Watch Madame Professor Marie Sklodowska Curie receiving the @RadiologyACR Gold Medal from Albert Soiland, founder of the ACR, and past president of @RadiumSociety, @RSNA, and @LARadiological Dr. Soiland was a #radonc
#WeWhoCurie #WomenWhoCurie @SimonLo21054188 @S_W_R_O
1
2
6
What is the role of pre-op RT in esophagus/GEJ cancer post ESOPEC & now MATTERHORN? I think we all agree pre-op RT not needed for all, but here is my take on 5 settings should still consider. Key is patient selection, weighing risks of local vs. distant recurrence. @OncoAlert
2
19
56
I’ll go beyond that and the probability that RTOG 1112 SBRT offers better survival than joint SARAH and SIRveNIB TARE Y90 is 97-98%
This is amazing and of critical importance for all fields- rad oncs control the dose , Y90 doesn’t , the meaning of small pockets of high dose distributed over a slower rate is also not efficacious - there’s a reason why there are 6 negative phase 3 trials - until dose uniformity
0
3
11
@HalletJulie @HopSTranCao @IDEALCollab @MiralGrandhiMD @ZhiVenFongMD @SocSurgOnc @IHPBA @AHPBA @EAHPBA @mcgillu @nyulangone @MDAndersonNews @MayoClinic @ESSOnews Histotripsy "is taking the HPB world by storm", powered largely by direct-to-patient Facebook ads and dramatic black-limo patient pickups rather than science...
1
1
6
Please vote for @herbloong outstanding #medonc global oncology leader & @DrMLChua brilliant #radonc clinician-scientist for @ASCO Board of Directors. The two great candidates from Asia will definitely shape the future of oncology！🌎💪📖🔬💊🌏
Voting for the @ASCO Election is now open! 🗳️ I am honoured to be running for the Designated #International #Oncologist seat 🌎. I am running alongside 12 other remarkable #candidates – visit https://t.co/qJMNn7j3kB to learn more about how each of us hopes to shape the future of
0
2
12
@SprakerMDPhD who were the responders? IMO: People will only know about “satisfaction” at least after 2 full years being in the position. So the best would be collecting data in the beginning of PGY4/PGY5 and then end of second year after accepting the position. There are also at least two
1
1
1
The 2026 Medicare Physician Fee Schedule (PFS) Final Rule is out, and it's a mixed bag. As President of ACRO, I'm breaking down what this complex rule really means for our specialty. At first glance, you'll see a 0% impact for radiation oncology, but this number is a statistical
0
1
3
As a medical profession we need to take posts like this one seriously It is a big problem (and undermines any hope of therapeutic alliance) if our patients don’t feel heard In fact I would argue that our jobs, both diagnostically and therapeutically, are easier when we listen
i hate doctors so much you literally have to manipulate them into doing their jobs. i’ve found doctors take me seriously when i act like i am unintelligent and uninformed. they don’t like patients using medical terms. only they are allowed to know those words
175
305
3K
This data is useful but does not completely address the concern as none of the participants have actually entered the workforce. Sounds like there will be an “early career” survey of people who have accepted *and* worked in the job. Will be extremely valuable.
A common concern last night: the job market. It’s becoming a tale as old as time…”the job market sucks!” Take a look at this years @ARRO_org survey data
2
0
4
Karyn Goodman is an aspirational clinician, trialist, leader & mentor. She is a role model to many (including myself). Please consider voting for her for @ASCO Board of Directors!
Voting for the ASCO election is now open! I am honored to be running as one of the candidates for the Designated Radiation Oncologist seat on the Board of Directors. Visit https://t.co/XPxOFR0twa to learn more about the candidates and place your vote!
2
4
31
I wouldn't recommend carbo/taxol + RT in patients with ILD and stage III lung cancer. There's good evidence that carbo/taxol has higher pneumonitis rates than etoposide/platinum. #FreeTheMicrotubules 🧵🧵🧵below....
🫁 Lung Cancer + Interstitial Lung Disease (ILD) 🌫️ 🎯 AIRO Delphi Consensus 2025 When fibrosis meets photons ⚡ 🇮🇹 Italian Association of Radiotherapy & Clinical Oncology (AIRO) brings expert guidance on how to safely deliver RT in this high-risk duo 👇 🧭 Key Recommendations
3
13
46
The CMS "we thought about it over the weekend" revisions...just incredible. But not half as incredible as the ASTRO summary. Despite their best efforts, our professional societies were unable to snatch defeat from the jaws of victory.
3
3
12
Fantastic article on Radiation Hysteria in the Age of Clicks #ALARA_Imaging @NEJM
https://t.co/RLOq2116Kt
Nice article by RO Resident Dr. Garlock on Simul's blog. It's time to admit that we can no longer assume integrity in peer-reviewed publishing. Important to investigate COI of any author making an argument.
3
2
14
Our JCAHO equivalent came by to bother us today, so someone confiscated the coffee and water I was recklessly consuming at my dictation desk between joint replacements. Thank you for keeping patients safe from hydrated, alert surgeons.
15
15
277
"Social Determinants Of Health: Recent CMMI pilot programs require physicians to collect data on housing, food, transportation, and other social determinants of health and then determine an appropriate intervention. Along with the checkbox, codes have arisen that reward
Over the past several decades, an appealing idea rapidly gained popularity: The government could advance a health care system that rewarded the quality of care rather than the volume of care. Medicare began leveraging its economic might to require physicians and hospitals to
16
19
73
The physician–scientist track (MD/PhD) in academic medical centers has become one of the great illusions of modern science - a path that promises to unite medicine and science but rarely fulfills either goal. Training stretches on for years as one person is expected to learn two
50
72
621
🗳️Poll for the #ProstateCancer session at #UromigosLive 2025: Considering VISION, PSMAFore and PSMAddition, in which prostate cancer disease state do you think the benefit/risk of Lu-PSMA-617 (Lutetium) is optimized? @OncoAlert @neerajaiims @charlesryanmd @DrRanaMcKay
2
15
18
Nice article by RO Resident Dr. Garlock on Simul's blog. It's time to admit that we can no longer assume integrity in peer-reviewed publishing. Important to investigate COI of any author making an argument.
0
4
18
Radiation dose in SBRT vs. Y90 in HCC. This confused me for the LONGEST time. Both measured in Gy, but clearly not the same – Y90 doses often reach 400Gy+, SBRT doses much lower (<50 Gy), yet both efficacious. Explained below. Bottom line is Y90 Gy ≠ SBRT Gy. @OncoAlert
12
31
99